The healthcare system is transitioning to value-based care. We can help you navigate the alphabet soup: APM, ACO, MSSP, EPM, MACRA, OCM, OBC. Count on us to guide you through the transition.
Proposed Requirements in 21st Century Cures Act Would Increase Transparency Requirements
The Center for Medicare & Medicaid Innovation is currently testing a variety of programs which place providers at risk for Medicare spending and may motivate providers to manage Medicare Part B costs, including drug spending and utilization.
Katherine Steinberg comes to Avalere Health with more than 15 years’ experience in the healthcare arena.
Earlier today, the Centers for Medicare and Medicaid Services (CMS) released participation information for its new Oncology Care Model (OCM) slated to begin July 1.
Avalere Supports the Robert Wood Johnson Foundation in Issuing Two Calls for Proposals
HHS released a proposed rule to MACRA which implements two pathways: Merit-Based Incentive Payment System and Advanced Alternative Payment Models. In this podcast, Avalere's Angel Valladares discusses the four performance categories.
According to a new analysis by Avalere, total profit margins for freestanding skilled nursing facilities (SNFs) in Pennsylvania decreased 28 percent between fiscal years (FY) 2007 and 2014, from 3.2 percent to 2.3 percent.
In our patient engagement series, hear Alex Goolsby discuss opportunities for provider organizations, health plans, patient advocacy groups, and drug and device manufacturers to engage patients through education and collaboration to improve healthcare.
In recent years, stakeholders have increasingly become aware of the potential opportunities surrounding incorporation of the patient perspective into early stages of drug development. Listen to Debleena Sengupta discuss how patient input is evaluated and incorporated into the FDA's decision-making process.
A new analysis from the National Health Council (NHC) and Genetic Alliance, with research and analytic support from Avalere Health, identifies critical barriers hindering the advancement of meaningful patient engagement and outlines tactical next steps for actionable solutions.
The health insurance company Aetna announced Friday it will buy rival Humana for $37 billion. The merger comes as other health insurers consider consolidating to cut costs. Read NPR's interview with our founder, Dan Mendelson.
Earlier this week, BioCentury featured guest commentary from Tanisha Carino and Reginald Williams about patient engagement.
Avalere Health and The SCAN Foundation partner to understand the interplay between medical and non-medical issues. Listen to Avalere’s Sally Rodriguez detail September’s white paper release.
The pressure to constrain healthcare costs, maximize clinical quality and improve patient experience has stimulated new approaches to measuring value, and places greater focus on the use of patient-reported outcome (PRO) based performance measures.
This month, Avalere Health proudly joins the Health Data Consortium (HDC), an organization comprising government, private sector, and non-for-profit entities, whose goal is to improve health and healthcare by advancing the availability and innovative use of data.